Cargando…

Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly

Introduction: The aim of this study was to analyze psychological factors of patients with acromegaly and assessment of their relationship with the quality of life (QoL) in the context of the control of the disease. Materials and methods: A total sample of 50 patients (62% of females; mean age = 51.6...

Descripción completa

Detalles Bibliográficos
Autores principales: Jawiarczyk-Przybyłowska, Aleksandra, Szcześniak, Dorota, Ciułkowicz, Marta, Bolanowski, Marek, Rymaszewska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972500/
https://www.ncbi.nlm.nih.gov/pubmed/32010060
http://dx.doi.org/10.3389/fendo.2019.00899
_version_ 1783489844966588416
author Jawiarczyk-Przybyłowska, Aleksandra
Szcześniak, Dorota
Ciułkowicz, Marta
Bolanowski, Marek
Rymaszewska, Joanna
author_facet Jawiarczyk-Przybyłowska, Aleksandra
Szcześniak, Dorota
Ciułkowicz, Marta
Bolanowski, Marek
Rymaszewska, Joanna
author_sort Jawiarczyk-Przybyłowska, Aleksandra
collection PubMed
description Introduction: The aim of this study was to analyze psychological factors of patients with acromegaly and assessment of their relationship with the quality of life (QoL) in the context of the control of the disease. Materials and methods: A total sample of 50 patients (62% of females; mean age = 51.66 ± 14.5) with acromegaly underwent a comparative, cross-sectional cohort assessment including the QoL (AcroQoL, WHOQoL-BREF), psychiatric morbidity (GHQ-28), the acceptance of illness (AIS) as well as influence of treatment, comorbidities and symptoms in the relation of disease activity. Acromegaly group was divided in two subgroups: patients with uncontrolled acromegaly (UA, n = 28) and patients with controlled acromegaly (CA, n = 22). Results: The acromegaly groups did not differ in health-related QoL measured with AcroQoL and WHOQoL questionnaires. However, obtained results showed QoL impairments in all subscales and the study participants had decreased scores compared to reference values. The interaction of the relationship between the AIS and disease activity as well as the prevalence of all psychopathological symptoms and disease activity were tested and the statistically significantly differences in the context of QoL in AcroQoL questionnaires and its domains were observed in relation to the course of the disease. No difference in acromegaly symptoms as well as in number of comorbidities were found between CA and UA but these two parameters affected the results QoL scores in AcroQol questionnaires and their domains, regardless the disease activity. Similarly, the prevalence of psychopathological symptoms (GHQ-28) contributed the level of acceptance of the disease, regardless the disease activity. The strongest predictors of QoL were related to the level of illness acceptance (p = 0.01) as well as serum growth hormone concentration. Conclusion: Minding people with UA, the control of biochemical factors seemed to be more important for the QoL perception, while among CA, psychological variables such as AIS are observed to play a fundamental role in QoL. Moreover, inclusion of patient's acceptance of the illness into clinical routine would promote holistic, patient-centered care and empower doctor-patient partnership where patients' expectations and perceptions are constantly tracked. Obtaining biochemical control should not be considered as the only measure of treatment success.
format Online
Article
Text
id pubmed-6972500
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69725002020-02-01 Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly Jawiarczyk-Przybyłowska, Aleksandra Szcześniak, Dorota Ciułkowicz, Marta Bolanowski, Marek Rymaszewska, Joanna Front Endocrinol (Lausanne) Endocrinology Introduction: The aim of this study was to analyze psychological factors of patients with acromegaly and assessment of their relationship with the quality of life (QoL) in the context of the control of the disease. Materials and methods: A total sample of 50 patients (62% of females; mean age = 51.66 ± 14.5) with acromegaly underwent a comparative, cross-sectional cohort assessment including the QoL (AcroQoL, WHOQoL-BREF), psychiatric morbidity (GHQ-28), the acceptance of illness (AIS) as well as influence of treatment, comorbidities and symptoms in the relation of disease activity. Acromegaly group was divided in two subgroups: patients with uncontrolled acromegaly (UA, n = 28) and patients with controlled acromegaly (CA, n = 22). Results: The acromegaly groups did not differ in health-related QoL measured with AcroQoL and WHOQoL questionnaires. However, obtained results showed QoL impairments in all subscales and the study participants had decreased scores compared to reference values. The interaction of the relationship between the AIS and disease activity as well as the prevalence of all psychopathological symptoms and disease activity were tested and the statistically significantly differences in the context of QoL in AcroQoL questionnaires and its domains were observed in relation to the course of the disease. No difference in acromegaly symptoms as well as in number of comorbidities were found between CA and UA but these two parameters affected the results QoL scores in AcroQol questionnaires and their domains, regardless the disease activity. Similarly, the prevalence of psychopathological symptoms (GHQ-28) contributed the level of acceptance of the disease, regardless the disease activity. The strongest predictors of QoL were related to the level of illness acceptance (p = 0.01) as well as serum growth hormone concentration. Conclusion: Minding people with UA, the control of biochemical factors seemed to be more important for the QoL perception, while among CA, psychological variables such as AIS are observed to play a fundamental role in QoL. Moreover, inclusion of patient's acceptance of the illness into clinical routine would promote holistic, patient-centered care and empower doctor-patient partnership where patients' expectations and perceptions are constantly tracked. Obtaining biochemical control should not be considered as the only measure of treatment success. Frontiers Media S.A. 2020-01-14 /pmc/articles/PMC6972500/ /pubmed/32010060 http://dx.doi.org/10.3389/fendo.2019.00899 Text en Copyright © 2020 Jawiarczyk-Przybyłowska, Szcześniak, Ciułkowicz, Bolanowski and Rymaszewska. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Jawiarczyk-Przybyłowska, Aleksandra
Szcześniak, Dorota
Ciułkowicz, Marta
Bolanowski, Marek
Rymaszewska, Joanna
Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
title Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
title_full Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
title_fullStr Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
title_full_unstemmed Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
title_short Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly
title_sort importance of illness acceptance among other factors affecting quality of life in acromegaly
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972500/
https://www.ncbi.nlm.nih.gov/pubmed/32010060
http://dx.doi.org/10.3389/fendo.2019.00899
work_keys_str_mv AT jawiarczykprzybyłowskaaleksandra importanceofillnessacceptanceamongotherfactorsaffectingqualityoflifeinacromegaly
AT szczesniakdorota importanceofillnessacceptanceamongotherfactorsaffectingqualityoflifeinacromegaly
AT ciułkowiczmarta importanceofillnessacceptanceamongotherfactorsaffectingqualityoflifeinacromegaly
AT bolanowskimarek importanceofillnessacceptanceamongotherfactorsaffectingqualityoflifeinacromegaly
AT rymaszewskajoanna importanceofillnessacceptanceamongotherfactorsaffectingqualityoflifeinacromegaly